Search Results
DDx Strength: Weak
tislelizumab, Rash or multiple lesions, 50-59 year old Female

Edit Findings
Exanthematous drug eruptionExanthematous drug eruption
Drug-induced hepatotoxicity
Pruritus without rashPruritus without rash
Erythema nodosumErythema nodosum
PsoriasisPsoriasis
Erythema multiformeErythema multiforme
Adrenal crisis
Drug-induced hypopigmentationDrug-induced hypopigmentation
Toxic epidermal necrolysisToxic epidermal necrolysis
Cutaneous adverse effects of immune checkpoint inhibitors
Drug-induced abdominal pain
Drug-induced cough
Drug-induced diarrhea
Drug-induced nausea or vomiting
Drug-induced weight gain
HypothyroidismHypothyroidism
Immune checkpoint inhibitor-related adverse effects
Colitis
Drug-induced anorexia
Drug-induced constipation
Drug-induced fatigue
Drug-induced fever
Drug-induced hematuria
Drug-induced leukopenia
Drug-induced myopathies
Drug-induced weight loss
GI bleeding
Hyperbilirubinemia
Hyperthyroidism
Hypokalemia
Hyponatremia
Acute liver failure
Drug-induced diabetes
Drug-induced dysphagia
Drug-induced weakness
Hypercalcemia
ThyroiditisThyroiditis
Drug-induced anemia
Cystitis
Acute kidney injury
Drug-induced arthralgia
Myocarditis
Drug-induced hypotension
Membranous nephropathy
Secondary adrenal insufficiency
Rhabdomyolysis
Myasthenia gravis